Therapeutic Drug Monitoring and Safety Considerations of Lithium Therapy in Mood Disorder
Abstract
Background: To study the Therapeutic Drug Monitoring and safety considerations of lithium in mood disorders. Methodology: The study was carried out for a period of six months, a total of 35 participants were screened from both in-patients and out-patients who visited the Department of Psychiatry, diagnosed with Mood Disorders and on lithium therapy. From that, 30 patients were enrolled into the study based on the inclusion and exclusion criteria. All categorical variables would be described as frequency and percentage. All continuous variables would be described as mean. Result: A total of 30 Bipolar Affective Disorder (BAPD) patients, in which 19 females and 11 males were enrolled in the study. The mean age of respondents was 45±15.59 (18-72 years). In post follow up, there was a significant increase in therapeutic level and reduction of sub-therapeutic and supra-therapeutic levels. Pearson Correlation between average serum lithium concentration and average total daily dose was found to be 0.9994 which means there is an extremely high positive linear correlation between variables. A consistent and strong relationship (0.9706) among patient weight and serum lithium levels. A strong positive correlation (0.996) among patient age and serum lithium levels. Conclusion: This study underscores that personalized lithium monitoring improves treatment outcomes and safety, with weight-based dosing offers potential benefit and large study needed for confirming long-term effects.
Keywords: TDM, Lithium, Drug Safety, ADR, BPAD
Keywords:
TDM, Lithium, Drug Safety, ADR, BPADDOI
https://doi.org/10.22270/jddt.v16i9.7978References
1. Datta S, Suryadevara U, Cheong J. Mood Disorders. Continuum (Minneap Minn).2021; 27(6):1712-1737. https://doi.org/10.1212/CON.0000000000001051 PMid:34881733
2. Spijker J, Claes S.Mood disorders in the DSM-5. Tijdschr psychiatry,2014;56(3):173-6.
3. Bocker, H,Norregaard, J,&Rafaelsen,O.J.(1976).Lithium treatment in manic-depressive illness: Clinical, pharmacokinetics and Biochemical aspects. Act Psychiatrica Scandinavica. Suoolements, 1976; 53(264),5-28.
4. Koda- Kimble MA, Young LY, Krradjan WA,Guglielmo BJ,Alldredge BK,Corelli RL, et al. Bipolar. In: Applied therapeutics: the clinical use of drugs. 2013,10th ed. Philadelphia: lippinocott Williams & wilkins; 1223-1246.
5. Moscoso D, Fernandes V, McGuire A, Craige E, dearlove G, Kennedy D, Ramiro M, Chandler G.Lithium therapeutics drug monitoring; once daily vs twice daily dosing and the impact of renal function. T Space Respository 2020.
6. Munshi S, Pal A. Exploring the role of therapeutic drug monitoring and regular supervision in optimizing quality of life in patients of bipolar affective disorders receiving lithium therapy in a tertiary care teaching hospital: a prospective observational study. Int J Res Med Sci2020:8(8):2013-2019. https://doi.org/10.18203/2320-6012.ijrms20203090
7. Sharma S, Joshi S, Chadda RK. Therapeutic drug monitoring of lithium in patients with bipolar affective disorders: experience from a tertiary care hospital in India. Am J Ther. 2009;16(5):393-7. https://doi.org/10.1097/MJT.0b013e31818a88da PMid:19262359
8. Kang JS, Lee MH, Overview of therapeutic drug monitoring. Korean J Intern Med.2009;24(1):1-10. https://doi.org/10.3904/kjim.2009.24.1.1 PMid:19270474 PMCid:PMC2687654
9. Glitlin M. et al, Lithium side effects and toxicity prevalence and management strategies. BJPsych Advances, (2016) 22(5),340 -345.
10. Malhi,G. S., Tanious, M, Das, P, Coulston, C.M. & Berk, M. (2017). The science and practice of lithium therapy. Australian & New Zealand Journal of Psychiatry (2017)51(10),884-898 Oellerich M, Kanzow P, Walson PD. Therapeutic drug monitoring- Key to personalized pharmacotherapy. Clin Biochem. 2017;50(7-8):375-379. https://doi.org/10.1007/978-3-319-45923-3
11. Bauer M, Pfennig A, Serverus E, Whybrow, P C Angst J & Moller H. J, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders: Update 2012 on lithium treatment. The World Journal of Biological Psychiatry, (2014)15(3), 195-222.
12. Lepkifker E, Dannon P. N, Iancu I, Ziv R, Grunhaus L, & Kotler M(1997). Lithium intoxication in psychiatric inpatients: a 5year survey. Journal of Clicical Psychiatry, (1997) 58(4), 169-172.
13. Rej S. Hermann, N. Shulman, K.I., The effects of age, renal function and medical comorbidity on lithium use in older adults: a systematic review. Journal of Geriatric Psychiatry and Neurology, (2014)27(1), 33-41.
14. National Institute for Health and Care Excellence(NICE). Bipolar disorder: Assessment and Management. NICE guideline [cg185](2022).
15. British National Formulary (BNF). Lithium. Retrieved from: (2024).
16. Grandjean, E M, Aubry, J M.. Lithium: Updated human knowledge using an evidence-based approach: part 2: Clinical Pharmacology and therapeutic monitoring. CNS Drugs, (2009)23(6), 531-549. https://doi.org/10.2165/00023210-200923040-00005 PMid:19374461
17. Airainer M, Seifert R. Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies. Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec; 397(12): 9723-9743. https://doi.org/10.1007/s00210-024-03210-8 PMid:38916833 PMCid:PMC11582333
18. Oellerich M, Kanzow P, Walson PD. Therapeutic drug monitoring- Key to personalized pharmacotherapy. ClinBiochem. 2017; 50(7-8): 375-379. https://doi.org/10.1016/j.clinbiochem.2017.01.007 PMid:28095311
19. Martin-Santiago O, et al. Understanding lithium intoxication in bipolar disorder: a comparative analysis and clinical implicatons. Eur Psychiatry. 2024 Aug 27; 67(Suppl 1): S298-S299. https://doi.org/10.1192/j.eurpsy.2024.622 PMCid:PMC11860270
20. Leo SL, et al. Challenges of Therapeutic Drug Monitoring and Usage of Lithium in Managing Psychiatric Disorders: A Review. Progress in Drug Discovery & Biomedical Science 2023, 6(1); 2-36. https://doi.org/10.36877/pddbs.a0000355
21. Singer BS, et al. Therapeutic Drug Monitoring of lithium therapy at psychiatric hospital in Nambia. PanAfr Med J. 2023 Jun 7; 45-78. https://doi.org/10.11604/pamj.2023.45.78.39862 PMid:37663635 PMCid:PMC10474807
22. Riedinger MA et al. Lithium in bipolar depression: A review of the evidemce. Hum Psychopharmaco. 2023 Sep; 38(5):e2881. https://doi.org/10.1002/hup.2881 PMid:37789577
23. Carli M et al. A 5-year study of lithium and valproic acid drug monitoring in patients with bipolar disorders in an Italian Clinical C enter. Pharmaceuticals (Basel). Pharmaceuticals (Basel). 2022 Jan 17; 15(1):105. https://doi.org/10.3390/ph15010105 PMid:35056162 PMCid:PMC8780673
24. Sheik M et al. A paper based calorimetric method for monitoring of lithium therapeutic levels. Anal Methods. 2023; 7. https://doi.org/10.1039/D2AY01743A PMid:36727666
25. Fountoulakis KN, et al. Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. Eur Neuropsychopharmacol. 2022 May: 20-29 https://doi.org/10.1016/j.euroneuro.2022.01.112 PMid:35158229
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Anne George , Alana Ansari , Alfa Mohammed , Aparna Sajeevan , Meera Ramanath , T Tamilselvan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.